September brought a series of pivotal updates in non–small cell lung cancer (NSCLC) treatment, including FDA regulatory decisions, late-breaking clinical trial results, and expert insights from the 2025
September 2025 Monthly Rewind: Key News and Expert Insights You May Have Missed in Lung Cancer
